Physician profile
Elaina Adderley
NPI 1699220988
$7,114.14
in general payments reported to CMS, 2019-2025
33 companies · $1,974 in 2025
The $1,974 reported for 2025 was more than what 76% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.00 · 2020: $126 · 2021: $346 · 2022: $1,254 · 2023: $1,733 · 2024: $1,660 · 2025: $1,974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,325 · Education: $42.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,324.62 |
| Education | $42.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,195.24 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $782.45 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Dexcom, INC. | $650.64 | 2021-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $417.69 | 2023-2025 | |
| Radius Health, INC. | $394.63 | 2024-2025 | Tymlos |
| Sanofi-Aventis U.S. LLC | $318.94 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $314.22 | 2021-2025 | Jardiance, Synjardy |
| Beta Bionics, INC. | $265.63 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Medtronic, INC. | $252.66 | 2022-2025 | Simplera Sensor, Minimed 780g |
| Amneal Pharmaceuticals LLC | $241.54 | 2023-2025 | Unithroid |
| Corcept Therapeutics | $206.10 | 2021-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $183.31 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $181.68 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Mannkind Corporation | $171.84 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $162.80 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $158.15 | 2021-2025 | |
| Antares Pharma, INC. | $148.72 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Amgen INC. | $129.97 | 2021-2025 | Tepezza, Repatha |
| Medtronic Minimed, INC. | $125.99 | 2020 | |
| Tandem Diabetes Care, INC. | $107.86 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Alexion Pharmaceuticals, INC. | $106.30 | 2022-2024 | Strensiq |
| Amryt Pharma Holdings Ltd | $104.35 | 2023 | Mycapssa |
| Insulet Corporation | $91.44 | 2022-2025 | Omnipod |
| Ibsa Pharma INC. | $83.29 | 2021-2025 | Flector, Licart, Tirosint |
| Abbott Laboratories | $81.54 | 2023-2025 | Freestyle Libre 3 |
| Recordati_rare_diseases_inc. | $60.12 | 2022-2025 | Isturisa |
| Pfizer INC. | $48.37 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $28.90 | 2025 | Evkeeza |
| Chiesi USA, INC. | $23.24 | 2025 | Mycapssa |
| Kyowa Kirin, INC. | $22.19 | 2023 | Crysvita |
| E.R. Squibb & Sons, L.L.C. | $21.00 | 2019 | |
| Glaxosmithkline, LLC. | $19.75 | 2025 | Shingrix, Arexvy |
| Horizon Therapeutics Plc | $13.59 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elaina Adderley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.